Showcases Stock ranks Forex

Ginkgo Bioworks Hldgs Inc (DNA)
1.27  0.04 (3.25%) 03-24 16:00
Open: 1.21 Pre. Close: 1.23
High: 1.3 Low: 1.2
Volume: 13,836,457 Market Cap: 2,611(M)
Stock Technical Analysis
Target: Six months: 1.80
One year: 2.06
Support: Support1: 1.19
Support2: 0.99
Resistance: Resistance1: 1.55
Resistance2: 1.76
Pivot: 1.29
Moving Averages: MA(5): 1.26
MA(20): 1.33
MA(100): 1.80
MA(250): 2.52
MACD: MACD(12,26): -0.10
Signal(12,26,9): -0.11
%K %D: %K(14,3): 22.73
%D(3): 26.57
RSI: RSI(14): 40.09
52-Week: High: 4.91
Low: 1.19
Change(%): -69.9
Average Vol(K): 3-Month: 20747
10-Days: 20332
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 1.302 - 1.307 1.307 - 1.312
Low: 1.188 - 1.193 1.193 - 1.198
Close: 1.261 - 1.27 1.27 - 1.278
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

[ DNA ] has closed above bottom band by 37.5%. Bollinger Bands are 64.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.
Company profile
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Stock chart
Stock News
Sat, 25 Mar 2023
Insider Selling: Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Insider ... - MarketBeat

Sat, 25 Mar 2023

Thu, 23 Mar 2023
Evaluating the Impact of -9.63 Increase on Ginkgo Bioworks ... - The News Heater

Wed, 22 Mar 2023
Luminar Technologies, EHang Holdings And Other Big Stocks ... - UK

Mon, 20 Mar 2023
As Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA)) market cap dropped by US$145m, insiders who sold US$79m worth of stock were able to offset their losses - Simply Wall St

Mon, 20 Mar 2023
Teachers Retirement System of The State of Kentucky Invests $2.86 ... - MarketBeat

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 1570.00
Shares Float (M) 1220.00
% Held by Insiders 9.33
% Held by Institutions 72.20
Shares Short (K) 146150
Shares Short Prior Month (K) 123490
Stock Financials
EPS -1.190
Book Value (p.s.) 0.920
Profit Margin
Operating Margin -461.89
Return on Assets (ttm) -59.8
Return on Equity (ttm) -127.5
Qtrly Rev. Growth -33.8
Gross Profit (p.s.) 0.174
Sales Per Share 0.304
EBITDA (p.s.) -1.376
Qtrly Earnings Growth
Operating Cash Flow (M) -252.20
Levered Free Cash Flow (M) 630.38
Stock Valuation
PE Ratio -1.07
PEG Ratio -0.09
Price to Book value 1.38
Price to Sales 4.17
Price to Cash Flow -7.91
Stock Dividends
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android